Publication | Closed Access

Vascularization in vivo caused by the controlled release of fibroblast growth factor-2 from an injectable chitosan/non-anticoagulant heparin hydrogel

Regenerative MedicineTissue EngineeringCell-based Drug DeliveryAngiogenesisFibroblast Growth Factor-2EngineeringBiomaterials DesignFibroblast Growth FactorVascular BiologyBiomedical EngineeringNeovascularizationMedicineBiomaterialsHeparins